Azoximer bromide
Azoximer bromide, sold by the trade name Polyoxidonium, is a macromolecular compound with high-molecular weight and high immunomodulating activity. It is used in Russia and CIS in treatment and prophylaxis of diseases connected with damage of immune system. It is a N-oxidized polyethylene–piperazine derivative.
![]() | |
Clinical data | |
---|---|
Other names | Polyoxidonium, Synpol |
ATC code | |
Pharmacokinetic data | |
Bioavailability | up to 89% |
Elimination half-life | 25.4 hours (intravenous routes) |
Identifiers | |
| |
CAS Number | |
ChemSpider |
|
UNII | |
Chemical and physical data | |
Formula | [[C8H15BrN2O2]x[C6H12N2O]y]n |
Molar mass | 60000–100000 g/mol |
Azoximer bromide is registered in US Patent-5503830 from 1996,[1][2][3] in the Russian Federation from 1996, under registration number 96/302/9, FS 42-3906-00.[4]
History
Polyoxidonium was created at the State Scientific Center of the Institute of Immunology of the Ministry of Health of the Russian Federation[5]. It is produced by NPO Petrovax Pharm LLC[6].
Medical uses
In adults with secondary immunodeficient states as:
- relapsing chronic bacterial infections
- relapsing chronic viral infections
- acute bacterial infections
- acute viral infections
- allergic diseases (pollinosis, bronchial asthma, atopic dermatitis)
- severe septic states
- postoperative complications - purulent infections
- when primary treatment develops cellular immunity decrease (cytostatic treatment, X-rays)
gollark: You can do that later.
gollark: It allocates memory and doesn't consider it a side effect.
gollark: I didn't do any horrible homoglyph hacks with THAT.
gollark: It uses the function, yes.
gollark: So, I finished that to highly dubious demand. I'd like to know how #11 and such work.
References
- https://www.google.com/patents/about?id=s9cfAAAAEBAJ&dq=US+5503830
- http://www.wikipatents.com/US-Patent-5503830/compounds-having-immunostimulating-activity-and-methods-of-use-thereof%5B%5D
- http://www.freepatentsonline.com/EP0789586.html
- State Scientific Centre of Russian federation, Immunological Institute of Russian Federation Health Resort, CLINICAL ASPECTS OF USE OF IMMUNOMODULATOR POLYOXIDONIUM, Methodical handbook for doctors issued by State Scientific Centre of Russian Federation – Immunological Institute of Russian Federation Health Resort Moscow – 2003
- Некрасов А. В., Пучкова Н. Г., Иванова А. С. и др. Производное поли-1,4-этиленпиперазина, обладающее иммуномодулирующей, противовирусной и антибактериальной активностью. Пат. РФ № 2073031, 1997.
- http://petrovax.com/medication/catalog/polyoxydonium/
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.